Maldonado-Montoro, Mar <br/><br/>
Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.  [electronic resource] 

 -  Pharmacological research  09 2016 
 - 264-271 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-1186 
<br/><br/><label>Standard No.: </label>10.1016/j.phrs.2016.06.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antigens, CD--genetics<br/>Antigens, Differentiation, T-Lymphocyte--genetics<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--blood<br/>Chi-Square Distribution<br/>Female<br/>Gene Frequency<br/>Genome-Wide Association Study<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Lectins, C-Type--genetics<br/>Linear Models<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>N-Acetylgalactosaminyltransferases--genetics<br/>Odds Ratio<br/>Pharmacogenetics<br/>Pharmacogenomic Testing<br/>Pharmacogenomic Variants<br/>Phenotype<br/>Predictive Value of Tests<br/>Recovery of Function<br/>Remission Induction<br/>Retrospective Studies<br/>Risk Factors<br/>Treatment Outcome<br/>Young Adult<br/>Polypeptide N-acetylgalactosaminyltransferase